s. pneumoniae whole cell vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02097472)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s. pneumoniae whole cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02543892 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2016 | PATH, University of London |
| NCT02097472 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2014 | Kenya Medical Research Institute, PATH |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PATH | Academic/Hospital | 2 | 2 | 1 | 2014 |
| Kenya Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1